跳至主要内容
临床试验/IRCT20211219053450N1
IRCT20211219053450N1尚未招募3 期

Effect of Empagliflozin on left ventricular volumes in type 2 diabetes or prediabetes patients with heart failure with reduced ejection fraction

Ahvaz University of Medical Sciences0 个研究点目标入组 112 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
112

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients with type 2 diabetes mellitus (HbA1C= 6.5%) or pre-diabetes (HbA1c between 5.7% to 6.4%) and ischemic heart failure with reduced fractional ejection (LVEF = 40%)
  • over 18 years old
  • Functional NYHA Class II to IV
  • Patient consent for participation in research

排除标准

  • Type 1 diabetes; Severe liver failure; eGFR History of diabetic ketoacidosis;
  • Existence of any malignancy and cancer;
  • Lack of adherence to the treatment regimen.

研究者

相似试验

招募中
2 期
The effect of Empagliflozin on left ventricular ejection fraction in non-diabetic patients with acute anterior ST elevation Myocardial infarction treated with primary PCIAcute anterior ST elevation Myocardial infarction treated with primary PCI.ST elevation (STEMI) myocardial infarction of anterior wallI21.0
IRCT20221227056950N1Mashhad University of Medical Sciences64
进行中(未招募)
1 期
Impact of empagliflozin on left ventricular functionstype 2 diabetesMedDRA version: 21.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disorders
EUCTR2016-002225-10-ITAZIENDA OSPEDALIERO-UNIVERSITARIA PISANA75
尚未招募
Unknown
The Impact of Empagliflozin on Left Ventricular Myocardial Stiffness in Heart Failure with Preserved Ejection FractioPatients with heart failure with preserved ejecion fraction (HFpEF)Drug intervention, Empagliflozin, Pressure-Volume LoopHFpEF/I509
JPRN-jRCTs071230020Hieda Michinari38
招募中
1 期
The impact of Empagliflozin on Left atrIal Volume and the feasibility of using Fitbit and mHealth to prescribe Exercise in non-diabetic Pre- Heart Failure(ELIVE pre-HF Study)Pre-Heart Failure (Non-diabetic)
CTIS2024-512062-34-00niversity College Dublin100
进行中(未招募)
1 期
Can Empagliflozin improve the structure of the heart in those with pre-Heart Failure and is it feasible to improve physical activity by using mHealth?pre-heart failure with preserved ejection fractionMedDRA version: 20.1Level: LLTClassification code 10076396Term: Heart failure with preserved ejection fractionSystem Organ Class: 100000004849
EUCTR2022-002650-48-IEniversity College Dublin100